Backed by
Building The Future of
Ingredient Supply Chains
At Anomaly, we focus on producing novel proteins using advanced fermentation; all we need is sugar, water, electricity, and a tank. A step change from current extraction-based methods.
By enabling on-demand production of critical ingredients free from biological or environmental constraints, our technology fuels economic growth and fortifies supply chains on a global scale.
With access to cutting-edge infrastructure for high-throughput experimental biology and automation across strain engineering and bioprocess optimisation for foundational R&D in Singapore, and with privileged access to commercial-scale fermentation facilities, we can go from idea to commercial deployment in under 12 months.
{ JOURNAL }
From the Lab
Follow our work, reserach, thinking in how we reimagine biology at scale for humanity
Backed by
Building The Future of
Ingredient Supply Chains
At Anomaly, we focus on producing novel proteins using advanced fermentation; all we need is sugar, water, electricity, and a tank. A step change from current extraction-based methods.
By enabling on-demand production of critical ingredients free from biological or environmental constraints, our technology fuels economic growth and fortifies supply chains on a global scale.
With access to cutting-edge infrastructure for high-throughput experimental biology and automation across strain engineering and bioprocess optimisation for foundational R&D in Singapore, and with privileged access to commercial-scale fermentation facilities, we can go from idea to commercial deployment in under 12 months.
{ JOURNAL }
From the Lab
Follow our work, reserach, thinking in how we reimagine biology at scale for humanity
Backed by
Building The Future of
Ingredient Supply Chains
At Anomaly, we focus on producing novel proteins using advanced fermentation; all we need is sugar, water, electricity, and a tank. A step change from current extraction-based methods.
By enabling on-demand production of critical ingredients free from biological or environmental constraints, our technology fuels economic growth and fortifies supply chains on a global scale.
With access to cutting-edge infrastructure for high-throughput experimental biology and automation across strain engineering and bioprocess optimisation for foundational R&D in Singapore, and with privileged access to commercial-scale fermentation facilities, we can go from idea to commercial deployment in under 12 months.
{ JOURNAL }
From the Lab
Follow our work, reserach, thinking in how we reimagine biology at scale for humanity